首页> 外文期刊>Journal of the American Chemical Society >Fidelity and Promiscuity of a Mycobacterial Glycosyltransferase
【24h】

Fidelity and Promiscuity of a Mycobacterial Glycosyltransferase

机译:分枝杆菌糖基转移酶的保真度和滥交性

获取原文
获取原文并翻译 | 示例
       

摘要

Members of the genus Mycobacterium cause devastating human diseases, including tuberculosis. Mycobacterium tuberculosis can resist some antibiotics because of its durable and impermeable cell envelope. This barrier is assembled from saccharide building blocks not found in mammals, including galactofuranose (Galf). Within the cell envelope, Galf residues are linked together to afford an essential polysaccharide, termed the galactan. The formation of this polymer is catalyzed by the glycosyltransferase GlfT2, a processive carbohydrate polymerase, which generates a sequence-specific polysaccharide with alternating regioisomeric β(1-5) and β(1-6) Gal/ linkages. GlfT2 exhibits high fidelity in linkage formation, as it will terminate polymerization rather than deviate from its linkage pattern. These findings suggest that GlfT2 would prefer an acceptor with a canonical alternating β(1-5) and β(1-6) Galf sequence. To test this hypothesis, we devised a synthetic route to assemble oligosaccharides with natural and non-natural sequences. GlfT2 could elongate each of these acceptors, even those with non-natural linkage patterns. These data indicate that the glycosyltransferase is surprisingly promiscuous in its substrate preferences. However, GlfT2 did favor some substrates: it preferentially acted on those in which the lipid-bearing Galf residue was connected to the sequence by a β(1-6) glycosidic linkage. The finding that the relative positioning of the lipid and the non-reducing end of the acceptor influences substrate selectivity is consistent with a role for the lipid in acceptor binding. The data also suggest that the fidelity of GlfT2 for generating an alternating β(1-5) and β(1- 6) pattern of Galf residues arises not from preferential substrate binding but during processive elongation. These observations suggest that inhibiting the action of GlfT2 will afford changes in cell wall structure.
机译:分枝杆菌属的成员引起毁灭性的人类疾病,包括结核病。结核分枝杆菌具有持久且不可渗透的细胞包膜,因此可以抵抗某些抗生素。这种屏障是由哺乳动物中未发现的糖类构造物组装而成的,包括半乳糖呋喃糖(半乳糖)。在细胞包膜内,Galf残基连接在一起以提供一种必需的多糖,称为半乳聚糖。该聚合物的形成是由糖基转移酶GlfT2(一种加工性碳水化合物聚合酶)催化的,该酶产生具有交替的区域异构体β(1-5)和β(1-6)Gal /键的序列特异性多糖。 GlfT2在键形成中表现出高保真度,因为它将终止聚合反应而不是偏离其键模式。这些发现表明,GlfT2更喜欢具有规范交替的β(1-5)和β(1-6)Galf序列的受体。为了验证该假设,我们设计了一种合成途径来组装具有天然和非天然序列的寡糖。 GlfT2可以延长这些受体的每个受体,甚至那些具有非天然连接模式的受体。这些数据表明,糖基转移酶在其底物偏好方面令人惊讶地混杂。但是,GlfT2确实偏爱某些底物:它优先作用于那些带有脂质的Galf残基通过β(1-6)糖苷键与序列相连的底物。脂质与受体的非还原端的相对位置影响底物选择性的发现与脂质在受体结合中的作用一致。数据还表明,用于产生交替的Galf残基的β(1-5)和β(1-6)模式的GlfT2保真度不是由优先的底物结合引起的,而是在进行性延伸过程中产生的。这些观察结果表明,抑制GlfT2的作用将改变细胞壁结构。

著录项

  • 来源
    《Journal of the American Chemical Society》 |2016年第29期|9205-9211|共7页
  • 作者单位

    Department of Chemistry, University of Wisconsin-Madison, 1101 University Avenue, Madison, Wisconsin 53706, United States,Graduate School of Pharmaceutical Sciences, The University of Tokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113-0033, Japan;

    Department of Chemistry, University of Wisconsin-Madison, 1101 University Avenue, Madison, Wisconsin 53706, United States,API Chemistry, GlaxoSmithKline, King of Prussia, PA;

    Department of Chemistry, University of Wisconsin-Madison, 1101 University Avenue, Madison, Wisconsin 53706, United States,Department of Biochemistry, University of Wisconsin-Madison, 433 Babcock Drive, Madison, Wisconsin 53706, United States;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 03:08:54

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号